Equivalent price position
Unlock the full competitive price benchmark
See the exact peer median, min/max and quartiles, product rank, price percentile and the complete like-for-like competitor table.
Price-position comparison uses current official listed prices normalized to compatible units. It is a price benchmark, not a measure of sales, demand, prescription volume or market share.
Product details
- Generic
- Atorvastatin
- Therapeutic area
- Cardiovascular
- Drug class
- HMG-CoA reductase inhibitors
- ATC
- C10AA05
- Strength
- 10 mg
- Dosage form
- Tablet
- Pack
- 10’s
- Registration no.
- 032065
- Price record verified
- 2026-08-08
- Latest DRAP source check
- 2026-09-25 03:02
Manufacturer
W. Woodward Pakistan (Pvt) Ltd.
Explore this manufacturer's complete MedInfoBase portfolio, generics and current listed prices.
View company portfolio →Official price over time
PKR 274.90 to 288.48 (+4.9%) between 2 Sep 2025 and 19 Aug 2026 · 2 official price records · pack 10’s
Step chart: a notified price holds until DRAP notifies the next one. Hover or tap a point for its date and change.
Cite this price history
MedInfoBase. Atvast Atvast 10 mg, 10’s: official price history (source: DRAP PharmaPrice Index). https://medinfobase.com/brand/atvast-atvast-10-mg-032065-10s-w-woodward-pakistan-pvt-ltd/ (accessed 25 September 2026).
Official price history
| Amount | Effective from | Verified | Source | Status |
|---|---|---|---|---|
| PKR 288.48 | 2026-08-19 | 2026-09-22 | DRAP PharmaPrice Index (refreshed from snapshot #84) | Current |
| PKR 274.90 | 2025-09-02 | 2026-08-08 | DRAP PharmaPrice Index | Historical |
Other listed brands
Cite this record
Medicine record · DRAP registration 032065Price and registration data on this page were observed on 22 September 2026. Records change over time, so please cite the observation date alongside the access date.
